Tillkännagivande • Jul 23
Resonance Specialties Limited to Report Q1, 2027 Results on Aug 04, 2026 Resonance Specialties Limited announced that they will report Q1, 2027 results on Aug 04, 2026 Upcoming Dividend • Jul 21
Upcoming dividend of ₹1.00 per share Eligible shareholders must have bought the stock before 28 July 2026. Payment date: 28 August 2026. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 0.7%. Lower than top quartile of Indian dividend payers (1.4%). In line with average of industry peers (0.8%). Reported Earnings • Jul 09
Full year 2026 earnings released: EPS: ₹9.01 (vs ₹5.69 in FY 2025) Full year 2026 results: EPS: ₹9.01 (up from ₹5.69 in FY 2025). Revenue: ₹902.5m (up 16% from FY 2025). Net income: ₹104.0m (up 58% from FY 2025). Profit margin: 12% (up from 8.4% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Jul 01
Resonance Specialties Limited, Annual General Meeting, Aug 04, 2026 Resonance Specialties Limited, Annual General Meeting, Aug 04, 2026, at 12:30 Indian Standard Time. Declared Dividend • May 16
Dividend of ₹1.00 announced Dividend of ₹1.00 is the same as last year. Ex-date: 28th July 2026 Payment date: 1st January 1970 Dividend yield will be 0.8%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (18% earnings payout ratio) and cash flows (9% cash payout ratio). The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has remained steady over the last 5 years. Unless this trend deteriorates, it should provide adequate earnings cover for the dividend. Tillkännagivande • May 15
Resonance Specialties Limited announces Annual dividend Resonance Specialties Limited announced Annual dividend of INR 1.0000 per share, ex-date on July 28, 2026 and record date on July 28, 2026. Tillkännagivande • May 02
Resonance Specialties Limited to Report Q4, 2026 Results on May 14, 2026 Resonance Specialties Limited announced that they will report Q4, 2026 results on May 14, 2026 New Risk • Apr 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 19% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (₹1.01b market cap, or US$10.8m). Valuation Update With 7 Day Price Move • Mar 31
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₹77.93, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 1.8% over the past three years. New Risk • Mar 30
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹899.6m (US$9.50m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (₹899.6m market cap, or US$9.50m). Minor Risk Paying a dividend despite having no free cash flows. Board Change • Mar 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Non-Executive Non- Independent Director Nilesh Jain was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 05
Third quarter 2026 earnings released: EPS: ₹2.18 (vs ₹0.96 in 3Q 2025) Third quarter 2026 results: EPS: ₹2.18 (up from ₹0.96 in 3Q 2025). Revenue: ₹232.9m (up 28% from 3Q 2025). Net income: ₹25.1m (up 125% from 3Q 2025). Profit margin: 11% (up from 6.1% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jan 30
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹108, the stock trades at a trailing P/E ratio of 16.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 11% over the past three years. Tillkännagivande • Jan 13
Resonance Specialties Limited to Report Q3, 2026 Results on Feb 04, 2026 Resonance Specialties Limited announced that they will report Q3, 2026 results on Feb 04, 2026 Reported Earnings • Nov 04
Second quarter 2026 earnings released: EPS: ₹1.44 (vs ₹1.55 in 2Q 2025) Second quarter 2026 results: EPS: ₹1.44 (down from ₹1.55 in 2Q 2025). Revenue: ₹218.9m (up 21% from 2Q 2025). Net income: ₹16.6m (down 8.2% from 2Q 2025). Profit margin: 7.6% (down from 10.0% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Tillkännagivande • Oct 15
Resonance Specialties Limited to Report Q2, 2026 Results on Nov 03, 2025 Resonance Specialties Limited announced that they will report Q2, 2026 results on Nov 03, 2025 Upcoming Dividend • Jul 22
Upcoming dividend of ₹1.00 per share Eligible shareholders must have bought the stock before 29 July 2025. Payment date: 29 August 2025. Payout ratio is a comfortable 18% but the company is not cash flow positive. Trailing yield: 0.9%. Lower than top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%). Tillkännagivande • Jul 21
Resonance Specialties Limited to Report Q1, 2026 Results on Aug 05, 2025 Resonance Specialties Limited announced that they will report Q1, 2026 results on Aug 05, 2025 Reported Earnings • Jul 11
Full year 2025 earnings released: EPS: ₹5.69 (vs ₹2.57 in FY 2024) Full year 2025 results: EPS: ₹5.69 (up from ₹2.57 in FY 2024). Revenue: ₹778.1m (up 41% from FY 2024). Net income: ₹65.7m (up 121% from FY 2024). Profit margin: 8.4% (up from 5.4% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Tillkännagivande • Jul 02
Resonance Specialties Limited, Annual General Meeting, Aug 05, 2025 Resonance Specialties Limited, Annual General Meeting, Aug 05, 2025, at 12:30 Indian Standard Time. New Risk • May 25
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 0.9% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 17% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹1.35b market cap, or US$15.9m). Tillkännagivande • May 20
Resonance Specialties Limited announces Annual dividend Resonance Specialties Limited announced Annual dividend of INR 1.0000 per share, ex-date on July 29, 2025 and record date on July 29, 2025. New Risk • May 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 17% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (₹1.02b market cap, or US$11.9m). Valuation Update With 7 Day Price Move • May 19
Investor sentiment improves as stock rises 34% After last week's 34% share price gain to ₹106, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 22% over the past three years. Valuation Update With 7 Day Price Move • Mar 27
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₹67.77, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 61% over the past three years. New Risk • Mar 26
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹821.8m (US$9.59m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 17% per year over the past 5 years. Market cap is less than US$10m (₹821.8m market cap, or US$9.59m). Reported Earnings • Jan 25
Third quarter 2025 earnings released: EPS: ₹0.96 (vs ₹0.83 in 3Q 2024) Third quarter 2025 results: EPS: ₹0.96 (up from ₹0.83 in 3Q 2024). Revenue: ₹185.4m (up 21% from 3Q 2024). Net income: ₹11.2m (up 16% from 3Q 2024). Profit margin: 6.0% (down from 6.3% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings. Tillkännagivande • Jan 08
Resonance Specialties Limited to Report Q3, 2025 Results on Jan 24, 2025 Resonance Specialties Limited announced that they will report Q3, 2025 results on Jan 24, 2025 Reported Earnings • Oct 24
Second quarter 2025 earnings released: EPS: ₹1.55 (vs ₹0.39 in 2Q 2024) Second quarter 2025 results: EPS: ₹1.55 (up from ₹0.39 in 2Q 2024). Revenue: ₹184.0m (up 81% from 2Q 2024). Net income: ₹18.1m (up 290% from 2Q 2024). Profit margin: 9.8% (up from 4.6% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Oct 23
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹110, the stock trades at a trailing P/E ratio of 47.4x. Average trailing P/E is 34x in the Chemicals industry in India. Total loss to shareholders of 48% over the past three years. Tillkännagivande • Oct 09
Resonance Specialties Limited to Report Q2, 2025 Results on Oct 23, 2024 Resonance Specialties Limited announced that they will report Q2, 2025 results on Oct 23, 2024 Tillkännagivande • Jul 22
Resonance Specialties Limited to Report Q1, 2025 Results on Aug 02, 2024 Resonance Specialties Limited announced that they will report Q1, 2025 results on Aug 02, 2024 Reported Earnings • Jul 09
Full year 2024 earnings released: EPS: ₹2.57 (vs ₹4.33 in FY 2023) Full year 2024 results: EPS: ₹2.57 (down from ₹4.33 in FY 2023). Revenue: ₹553.0m (down 6.0% from FY 2023). Net income: ₹29.7m (down 41% from FY 2023). Profit margin: 5.4% (down from 8.5% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings. Tillkännagivande • Jul 04
Resonance Specialties Limited, Annual General Meeting, Aug 02, 2024 Resonance Specialties Limited, Annual General Meeting, Aug 02, 2024, at 15:00 Indian Standard Time. Reported Earnings • May 16
Full year 2024 earnings released: EPS: ₹2.56 (vs ₹4.33 in FY 2023) Full year 2024 results: EPS: ₹2.56 (down from ₹4.33 in FY 2023). Revenue: ₹562.3m (down 4.4% from FY 2023). Net income: ₹29.7m (down 41% from FY 2023). Profit margin: 5.3% (down from 8.5% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Tillkännagivande • May 08
Resonance Specialties Limited to Report Q4, 2024 Results on May 14, 2024 Resonance Specialties Limited announced that they will report Q4, 2024 results on May 14, 2024 Valuation Update With 7 Day Price Move • Apr 09
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹109, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 13% over the past three years. Reported Earnings • Feb 07
Third quarter 2024 earnings released: EPS: ₹0.83 (vs ₹0.75 in 3Q 2023) Third quarter 2024 results: EPS: ₹0.83 (up from ₹0.75 in 3Q 2023). Revenue: ₹156.0m (up 69% from 3Q 2023). Net income: ₹9.61m (up 11% from 3Q 2023). Profit margin: 6.2% (down from 9.4% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Tillkännagivande • Jan 19
Resonance Specialties Limited to Report Nine Months, 2024 Results on Feb 06, 2024 Resonance Specialties Limited announced that they will report nine months, 2024 results on Feb 06, 2024 Valuation Update With 7 Day Price Move • Dec 29
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹112, the stock trades at a trailing P/E ratio of 37.5x. Average trailing P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 27% over the past three years. Reported Earnings • Nov 04
Second quarter 2024 earnings released: EPS: ₹0.39 (vs ₹1.24 in 2Q 2023) Second quarter 2024 results: EPS: ₹0.39 (down from ₹1.24 in 2Q 2023). Revenue: ₹103.9m (down 31% from 2Q 2023). Net income: ₹4.63m (down 66% from 2Q 2023). Profit margin: 4.5% (down from 9.1% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Tillkännagivande • Oct 19
Resonance Specialties Limited to Report Q2, 2024 Results on Nov 03, 2023 Resonance Specialties Limited announced that they will report Q2, 2024 results on Nov 03, 2023 Tillkännagivande • Aug 30
Resonance Specialties Limited Approves Appointment of Vaibhavi Rajeshirke as Company Secretary & Compliance Officer Resonance Specialties Limited announced that at its board meeting held on August 30, 2023, the Board has appointed Ms. Vaibhavi Rajeshirke as the company secretary & compliance officer and nodal officer for IEPF of the company with effect from August 30, 2023. Ms. Vaibhavi Rajeshirke, aged 29 years is a post graduate in commerce (M.COM) and is also an Associate Member of the Institute of Company Secretaries of India, Membership no ACS 72229. She has nearly 2 years experience in the field of Compliances and Company Secretarial functions. Upcoming Dividend • Jul 25
Upcoming dividend of ₹1.00 per share at 1.1% yield Eligible shareholders must have bought the stock before 01 August 2023. Payment date: 07 September 2023. Payout ratio is a comfortable 23% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.9%). Tillkännagivande • Jul 24
Resonance Specialties Limited to Report Q1, 2024 Results on Aug 08, 2023 Resonance Specialties Limited announced that they will report Q1, 2024 results on Aug 08, 2023 Tillkännagivande • Jul 12
Resonance Specialties Limited Recommends Dividend for the Financial Year Ended March 31, 2023, Payable on or Before August 31, 2023 The Board of Resonance Specialties Limited has recommended a dividend of INR 1 per share (10%) for the financial year ended 31st March, 2023 on its equity shares of face value of INR 10 each which if sanctioned will be paid on or before August 31, 2023. Reported Earnings • Jul 12
Full year 2023 earnings released: EPS: ₹4.33 (vs ₹10.71 in FY 2022) Full year 2023 results: EPS: ₹4.33 (down from ₹10.71 in FY 2022). Revenue: ₹588.1m (down 22% from FY 2022). Net income: ₹50.0m (down 60% from FY 2022). Profit margin: 8.5% (down from 16% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 13% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Jul 06
Resonance Specialties Limited, Annual General Meeting, Aug 08, 2023 Resonance Specialties Limited, Annual General Meeting, Aug 08, 2023, at 15:30 Indian Standard Time. Reported Earnings • May 15
Full year 2023 earnings released: EPS: ₹4.37 (vs ₹10.71 in FY 2022) Full year 2023 results: EPS: ₹4.37 (down from ₹10.71 in FY 2022). Revenue: ₹604.3m (down 20% from FY 2022). Net income: ₹50.0m (down 60% from FY 2022). Profit margin: 8.3% (down from 16% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • May 12
Resonance Specialties Limited Proposes Dividend for the Financial Year 2022-23 Resonance Specialties Limited at its board of directors meeting held on May 11, 2023 declared a dividend of INR 1 per share (10%) for the financial year 2022-23 subject to the approval of the Shareholders at the forthcoming Annual General Meeting. Buying Opportunity • Feb 27
Now 23% undervalued after recent price drop Over the last 90 days, the stock is down 14%. The fair value is estimated to be ₹129, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.7% over the last 3 years. Earnings per share has grown by 13%. Reported Earnings • Feb 05
Third quarter 2023 earnings released: EPS: ₹0.75 (vs ₹2.51 in 3Q 2022) Third quarter 2023 results: EPS: ₹0.75 (down from ₹2.51 in 3Q 2022). Revenue: ₹93.9m (down 46% from 3Q 2022). Net income: ₹8.70m (down 70% from 3Q 2022). Profit margin: 9.3% (down from 17% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Jan 25
Resonance Specialties Limited to Report Q3, 2023 Results on Feb 02, 2023 Resonance Specialties Limited announced that they will report Q3, 2023 results on Feb 02, 2023 Board Change • Nov 16
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. Independent Chairperson Archana Yadav is the most experienced director on the board, commencing their role in 2016. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 11
Second quarter 2023 earnings released: EPS: ₹1.24 (vs ₹2.99 in 2Q 2022) Second quarter 2023 results: EPS: ₹1.24 (down from ₹2.99 in 2Q 2022). Revenue: ₹158.2m (down 14% from 2Q 2022). Net income: ₹13.8m (down 59% from 2Q 2022). Profit margin: 8.7% (down from 18% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 52% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Nov 02
Resonance Specialties Limited to Report Q2, 2023 Results on Nov 09, 2022 Resonance Specialties Limited announced that they will report Q2, 2023 results on Nov 09, 2022 Buying Opportunity • Aug 29
Now 23% undervalued Over the last 90 days, the stock is up 5.6%. The fair value is estimated to be ₹203, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 35%. Buying Opportunity • Aug 14
Now 20% undervalued Over the last 90 days, the stock is up 17%. The fair value is estimated to be ₹206, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 35%. Tillkännagivande • Aug 03
Resonance Specialties Limited to Report Q1, 2023 Results on Aug 11, 2022 Resonance Specialties Limited announced that they will report Q1, 2023 results on Aug 11, 2022 Board Change • Aug 01
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Chairperson Archana Yadav is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Upcoming Dividend • Jul 28
Upcoming dividend of ₹1.00 per share Eligible shareholders must have bought the stock before 04 August 2022. Payment date: 09 September 2022. Payout ratio is a comfortable 9.3% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.8%). Lower than average of industry peers (0.8%). Reported Earnings • Jul 17
Full year 2022 earnings released: EPS: ₹10.64 (vs ₹9.12 in FY 2021) Full year 2022 results: EPS: ₹10.64 (up from ₹9.12 in FY 2021). Revenue: ₹771.1m (up 8.8% from FY 2021). Net income: ₹123.6m (up 17% from FY 2021). Profit margin: 16% (up from 15% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jun 24
Investor sentiment improved over the past week After last week's 21% share price gain to ₹166, the stock trades at a trailing P/E ratio of 16x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 326% over the past three years. Tillkännagivande • Jun 23
Resonance Specialties Limited, Annual General Meeting, Aug 11, 2022 Resonance Specialties Limited, Annual General Meeting, Aug 11, 2022. Agenda: To consider approval of dividend; to consider appointment of Mr. Charchit Jain as an Additional and Whole-time Director of the Company; and to consider other matters. Tillkännagivande • May 05
Resonance Specialties Limited to Report Q4, 2022 Results on May 11, 2022 Resonance Specialties Limited announced that they will report Q4, 2022 results on May 11, 2022 Board Change • Apr 27
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Chairperson Archana Yadav is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Valuation Update With 7 Day Price Move • Dec 09
Investor sentiment improved over the past week After last week's 21% share price gain to ₹218, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 743% over the past three years. Reported Earnings • Oct 28
Second quarter 2022 earnings released: EPS ₹2.99 (vs ₹3.44 in 2Q 2021) The company reported a poor second quarter result with weaker earnings and revenues, although profit margins were flat. Second quarter 2022 results: Revenue: ₹189.4m (down 17% from 2Q 2021). Net income: ₹33.5m (down 16% from 2Q 2021). Profit margin: 18% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has increased by 105% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Sep 13
Investor sentiment improved over the past week After last week's 31% share price gain to ₹229, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 797% over the past three years. Upcoming Dividend • Aug 11
Upcoming dividend of ₹1.00 per share Eligible shareholders must have bought the stock before 18 August 2021. Payment date: 25 September 2021. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.5%). In line with average of industry peers (0.7%). Reported Earnings • Aug 05
Full year 2021 earnings released: EPS ₹9.12 (vs ₹4.77 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹709.0m (up 24% from FY 2020). Net income: ₹105.2m (up 91% from FY 2020). Profit margin: 15% (up from 9.6% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 75% per year but the company’s share price has increased by 96% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 17
Investor sentiment improved over the past week After last week's 18% share price gain to ₹172, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 740% over the past three years. Reported Earnings • Jun 05
Full year 2021 earnings released: EPS ₹8.78 (vs ₹4.77 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹718.7m (up 25% from FY 2020). Net income: ₹105.2m (up 91% from FY 2020). Profit margin: 15% (up from 9.6% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has increased by 81% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • May 29
Investor sentiment improved over the past week After last week's 16% share price gain to ₹154, the stock trades at a trailing P/E ratio of 19.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 509% over the past three years. Valuation Update With 7 Day Price Move • Apr 27
Investor sentiment improved over the past week After last week's 17% share price gain to ₹142, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 357% over the past three years. Reported Earnings • Feb 07
Third quarter 2021 earnings released: EPS ₹2.82 (vs ₹2.09 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹187.5m (up 11% from 3Q 2020). Net income: ₹36.3m (up 50% from 3Q 2020). Profit margin: 19% (up from 14% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 70% per year, which means it is significantly lagging earnings growth. Is New 90 Day High Low • Feb 03
New 90-day high: ₹158 The company is up 166% from its price of ₹59.35 on 05 November 2020. The Indian market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period. Tillkännagivande • Jan 25
Resonance Specialties Limited to Report Q3, 2021 Results on Feb 05, 2021 Resonance Specialties Limited announced that they will report Q3, 2021 results on Feb 05, 2021 Valuation Update With 7 Day Price Move • Jan 21
Investor sentiment improved over the past week After last week's 19% share price gain to ₹154, the stock is trading at a trailing P/E ratio of 21.5x, up from the previous P/E ratio of 18.1x. This compares to an average P/E of 19x in the Chemicals industry in India. Total returns to shareholders over the past three years are 323%. Valuation Update With 7 Day Price Move • Dec 29
Investor sentiment improved over the past week After last week's 16% share price gain to ₹135, the stock is trading at a trailing P/E ratio of 18.7x, up from the previous P/E ratio of 16.2x. This compares to an average P/E of 18x in the Chemicals industry in India. Total returns to shareholders over the past three years are 217%. Valuation Update With 7 Day Price Move • Dec 15
Investor sentiment improved over the past week After last week's 16% share price gain to ₹105, the stock is trading at a trailing P/E ratio of 14.7x, up from the previous P/E ratio of 12.7x. This compares to an average P/E of 17x in the Chemicals industry in India. Total returns to shareholders over the past three years are 245%. Is New 90 Day High Low • Dec 15
New 90-day high: ₹105 The company is up 72% from its price of ₹61.15 on 15 September 2020. The Indian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. Tillkännagivande • Nov 20
Resonance Specialties Limited Announces Board Changes Resonance Specialties Limited announced that the appointment of Mr. Raj Kamal Prasad Verma as an Additional Director (Non-Executive & Independent), on the board of directors of Resonance Specialties Limited, it has been resolved to reconstitute Audit Committee of the Company and accordingly the Board of Directors of the Company vide Circular resolution dated November 18, 2020, have approved and reconstituted the following Committees of the Board with immediate effect: The audit committee is appointed Ms. Archana Surendra Yadav as chairman, Mr. Raj Kamal Prasad Verma, Mr. Bishwanath Prasad Agrawal and Mr. Ajay Patadia as members. The nomination and remuneration committee is appointed Mr. Raj Kamal Prasad Verma as chairman, Ms. Archana Surendra Yadav, Mr. Bishwanath Prasad Agrawal and Mr. Ajay Patadia as members. Stakeholders Relationship Committee is appointed Mr. Bishwanath Prasad Agrawal as chairman, Ms. Archana Surendra Yadav, Mr. Atma Bandhu Gupta and Mr. Raj Kamal Prasad Verma as members. Corporate Social Responsibility Committee is appointed Mr. Atma Bandhu Gupta as chairman, Mr. Bishwanath Prasad Agrawal, Ms. Archana Surendra Yadav and Mr. Raj Kamal Prasad Verma as members. Reported Earnings • Nov 13
Second quarter 2021 earnings released: EPS ₹3.44 The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹227.6m (up 68% from 2Q 2020). Net income: ₹39.8m (up 254% from 2Q 2020). Profit margin: 18% (up from 8.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Nov 12
Market bids up stock over the past week After last week's 18% share price gain to ₹69.85, the stock is trading at a trailing P/E ratio of 15x, up from the previous P/E ratio of 12.7x. This compares to an average P/E of 15x in the Chemicals industry in India. Total returns to shareholders over the past three years are 129%. Is New 90 Day High Low • Nov 12
New 90-day high: ₹69.85 The company is up 49% from its price of ₹46.80 on 14 August 2020. The Indian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period. Tillkännagivande • Sep 09
Resonance Specialties Limited to Report Q1, 2021 Results on Sep 15, 2020 Resonance Specialties Limited announced that they will report Q1, 2021 results on Sep 15, 2020 Tillkännagivande • Aug 08
Resonance Specialties Limited Expects to Full Plant Operations in Couple of Months Resonance Specialties Limited announced that due to COVID-19 outbreak and as per directives issued by the Government of India, State Governments and other regulatory authorities, the company had temporarily suspended manufacturing in company's Plant. Operations were partially resumed and full resumption is expected in next couple of months. The Company has also Implemented Work from Home Policy for its employees to ensure compliance with Government's directives and to safeguard employee's health and safety. Tillkännagivande • Jul 05
Resonance Specialties Limited to Report Q4, 2020 Results on Jul 31, 2020 Resonance Specialties Limited announced that they will report Q4, 2020 results on Jul 31, 2020 
